| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 25/07/2017 | 14:00 | Business Wire | NantKwest Announces Publication of Preclinical Data of haNK Cell Therapy in Combination with Checkpoint Inhibitor Avelumab Pr... | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 07/02/2013 | 12:52 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (sc 13e3/a) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 07/02/2013 | 12:24 | Edgar (US Regulatory) | Report of Foreign Issuer (6-k) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 07/02/2013 | 10:54 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Announces Completion of Merger | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 06/02/2013 | 23:14 | Edgar (US Regulatory) | (25-NSE) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 29/01/2013 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. to Reconvene Adjourned Extraordinary General Meeting of Shareholders | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/01/2013 | 15:03 | Edgar (US Regulatory) | Amended Statement of Ownership: Private Transaction (SC 13E3/A) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/01/2013 | 13:28 | Edgar (US Regulatory) | Report of Foreign Issuer (6-K) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/01/2013 | 10:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Adjourns Extraordinary General Meeting of Shareholders | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 14/01/2013 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Proposes to Adjourn Extraordinary General Meeting of Shareholders | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 14/12/2012 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Announces Extraordinary General Meeting of Shareholders | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 25/11/2012 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Reports Third Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 05/11/2012 | 14:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. to Report Third Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 12/10/2012 | 23:00 | Edgar (US Regulatory) | Statement of Ownership: Private Transaction (SC 13E3) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 06/10/2012 | 18:11 | Business Wire | Rosen Law Firm Announces Investigation of China Nuokang Bio-Pharmaceutical In Connection With Going Private Proposal from Kin... | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 27/09/2012 | 23:15 | Dow Jones News | ADR Report: Shares End Higher; Resource Firms Gain | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 27/09/2012 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Enters Into Definitive Agreement for Going Private Transaction | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 22/08/2012 | 22:01 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Reports Second Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 01/08/2012 | 14:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. to Report Second Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/06/2012 | 14:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Announces Change in CFO | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 08/06/2012 | 16:11 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 04/06/2012 | 14:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Appoints Lazard and Houlihan Lokey as Independent Financial Advisors to Evaluate "Going... | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 23/05/2012 | 22:01 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Reports First Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 21/05/2012 | 14:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Forms Independent Committee and Appoints Independent Legal Counsel to Evaluate "Going P... | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/05/2012 | 12:20 | Edgar (US Regulatory) | Amended Annual and Transition Report (foreign private issuer) (20-F/A) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 10/05/2012 | 15:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. to Report First Quarter 2012 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 09/05/2012 | 13:00 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Announces Receipt of "Going Private" Proposal | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 24/04/2012 | 22:33 | Edgar (US Regulatory) | Annual and Transition Report (foreign private issuer) (20-F) | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 15/03/2012 | 04:59 | GlobeNewswire Inc. | CORRECTING and REPLACING -- China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |
| 14/03/2012 | 21:01 | GlobeNewswire Inc. | China Nuokang Bio-Pharmaceutical Inc. Reports Fourth Quarter and Full Year 2011 Financial Results | NASDAQ:NKBP | China Nuokang Bio-Pharmaceutical Inc. ADS, Each Representing Eight Ordinary Shares (MM) |